News on immunoassay systems and applications.
GenScript's test measures the presence of neutralizing antibodies for SARS-CoV-2 and has received EUA from the US Food and Drug Administration.
DiaSorin said that the acquisition gives it access to Luminex's multiplexing technology, tests, and instruments and strengthens its MDx product portfolio.
The test, which runs on Ortho's Vitros system, was first CE marked in October for use with nasopharyngeal swab specimens and certain viral transport media.
The technology underlying the test was developed by Dutch firm Minicare, which was acquired by Siemens in 2019.
The companies began working together in 2018, when MEDx was known as Qiagen Translational Medicine, on companion and in vitro diagnostics.
